175 related articles for article (PubMed ID: 34445725)
21. Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats.
Zhou J; Lei Y; Chen J; Zhou X
Int Immunopharmacol; 2018 Nov; 64():162-169. PubMed ID: 30179845
[TBL] [Abstract][Full Text] [Related]
22. Hesperidin ameliorates benign prostatic hyperplasia by attenuating cell proliferation, inflammatory response, and epithelial-mesenchymal transition via the TGF-β1/Smad signaling pathway.
Kim HJ; Jin BR; An HJ
Biomed Pharmacother; 2023 Apr; 160():114389. PubMed ID: 36791565
[TBL] [Abstract][Full Text] [Related]
23. Kolaviron modulates angiogenesis, apoptosis and inflammatory signaling in rat model of testosterone propionate-induced benign prostate hyperplasia.
Farombi EO; Ajayi BO; Opata EK; Fafioye AO; Akinade AT
Inflammopharmacology; 2023 Aug; 31(4):2121-2131. PubMed ID: 36881348
[TBL] [Abstract][Full Text] [Related]
24. Linh Phu Khang Tue Tinh inhibited prostate proliferation in rats induced benign prostatic hyperplasia by testosterone propionate.
Minh TD; Thanh Ha TN; Duy TN; Hoang NN; PhamTien D; Thai HP; Thi HN; Thi Lan PD; Quoc BP; Ivkin DY; Povydysh MN; Cong BN; Krasnova MV
J Ethnopharmacol; 2021 Oct; 279():114388. PubMed ID: 34224813
[TBL] [Abstract][Full Text] [Related]
25. Ellagic acid improves benign prostate hyperplasia by regulating androgen signaling and STAT3.
Park WY; Song G; Park JY; Ahn KS; Kwak HJ; Park J; Lee JH; Um JY
Cell Death Dis; 2022 Jun; 13(6):554. PubMed ID: 35715415
[TBL] [Abstract][Full Text] [Related]
26. Pao Pereira Extract Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by inhibiting 5α-Reductase.
Liu J; Fang T; Li M; Song Y; Li J; Xue Z; Li J; Bu D; Liu W; Zeng Q; Zhang Y; Yun S; Huang R; Yan J
Sci Rep; 2019 Dec; 9(1):19703. PubMed ID: 31873149
[TBL] [Abstract][Full Text] [Related]
27. Botanical Formulation HX109 Ameliorates TP-Induced Benign Prostate Hyperplasia in Rat Model and Inhibits Androgen Receptor Signaling by Upregulating Ca
Lim S; Lee W; Lee DS; Nam IJ; Yun N; Jeong Y; Rho T; Kim S
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30544543
[TBL] [Abstract][Full Text] [Related]
28. [Ruyi Jinhuang Plaster suppresses BPH by reducing the expressions of P38, JNK2, NF-кBP65 and STAT3 in the prostate tissue of rats].
Liu MY; Chi NJ; Feng J; Shi XP; Wen AD
Zhonghua Nan Ke Xue; 2018 Dec; 24(12):1116-1121. PubMed ID: 32212493
[TBL] [Abstract][Full Text] [Related]
29. Flaxseed suppressed prostatic epithelial proliferation in a rat model of benign prostatic hyperplasia.
Said MM; Hassan NS; Schlicht MJ; Bosland MC
J Toxicol Environ Health A; 2015; 78(7):453-65. PubMed ID: 25785559
[TBL] [Abstract][Full Text] [Related]
30. Anti-Proliferative Effects of HBX-5 on Progression of Benign Prostatic Hyperplasia.
Jin BR; Kim HJ; Park SK; Kim MS; Lee KH; Yoon IJ; An HJ
Molecules; 2018 Oct; 23(10):. PubMed ID: 30322186
[TBL] [Abstract][Full Text] [Related]
31. Effect of
Choi YJ; Kim EK; Fan M; Tang Y; Hwang YJ; Sung SH
Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31591335
[No Abstract] [Full Text] [Related]
32. HBX-6, Standardized
Jin BR; Kim HJ; Seo JH; Kim MS; Lee KH; Yoon IJ; An HJ
Molecules; 2019 May; 24(9):. PubMed ID: 31052610
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L.
Deng L; Zong W; Tao X; Liu S; Feng Z; Lin Y; Liao Z; Chen M
J Ethnopharmacol; 2019 Mar; 232():1-10. PubMed ID: 30529422
[TBL] [Abstract][Full Text] [Related]
34. Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH).
Lai KP; Huang CK; Fang LY; Izumi K; Lo CW; Wood R; Kindblom J; Yeh S; Chang C
Mol Endocrinol; 2013 Oct; 27(10):1617-31. PubMed ID: 23893956
[TBL] [Abstract][Full Text] [Related]
35. Febuxostat attenuates testosterone-induced benign prostatic hyperplasia in rats via inhibiting JAK/STAT axis.
Abo-Youssef AM; Afify H; Azouz AA; Abdel-Rahman HM; Abdel-Naim AB; Allam S
Life Sci; 2020 Nov; 260():118414. PubMed ID: 32926929
[TBL] [Abstract][Full Text] [Related]
36. The therapeutic effects of Stauntonia hexaphylla in benign prostate hyperplasia are mediated by the regulation of androgen receptors and 5α-reductase type 2.
Hong GL; Park SR; Jung DY; Karunasagara S; Lee KP; Koh EJ; Cho K; Park SS; Jung JY
J Ethnopharmacol; 2020 Mar; 250():112446. PubMed ID: 31812646
[TBL] [Abstract][Full Text] [Related]
37. Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents.
Kumar R; Verma V; Sarswat A; Maikhuri JP; Jain A; Jain RK; Sharma VL; Dalela D; Gupta G
Invest New Drugs; 2012 Apr; 30(2):582-93. PubMed ID: 21181231
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effects of
Choi YJ; Fan M; Wedamulla NE; Tang Y; Bae SM; Hwang JY; Kim EK
Food Funct; 2022 Oct; 13(19):10235-10247. PubMed ID: 36124918
[No Abstract] [Full Text] [Related]
39. In Vivo Effects of Polymerized Anthocyanin from Grape Skin on Benign Prostatic Hyperplasia.
Choi YJ; Fan M; Tang Y; Yang HP; Hwang JY; Kim EK
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31615010
[TBL] [Abstract][Full Text] [Related]
40. Effects of Lespedeza Cuneata aqueous extract on testosterone-induced prostatic hyperplasia.
Park BK; Kim CW; Kwon JE; Negi M; Koo YT; Lee SH; Baek DH; Noh YH; Kang SC
Pharm Biol; 2019 Dec; 57(1):90-98. PubMed ID: 30724641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
